Efficacy, Safety, and Pharmacokinetic Profile of Etokimab (ANB020) in Adult Participants With Moderate-to-Severe Atopic Dermatitis
Clinical trial NCT03533751 · COMPLETED
Trial details
- NCT number
- NCT03533751
- Sponsor
- AnaptysBio, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-19
- Primary completion
- 2019-12-03
- Enrollment
- 302
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.